press

Historical Implications for Today’s Embryo Transfer: Day 3 Vs. Day 5 by G. John Garrisi, Ph.D.

Which is better for success? A day 5 transfer of embryos or a day 3 transfer?

Can Preimplantation Genetic Diagnosis (PGD) Reduce the Risk for Recurrent Pregnancy Loss? By Serena Chen, M.D.

Preimplantation Genetic Diagnosis or PGD is an exciting new technology that can detect some genetic abnormalities. PGD may also be an option for women who suffer recurrent first trimester pregnancy loss, for women with a history of a chromosomally abnormal pregnancy, and for women with age-related infertility.

Finding Your Assisted Reproduction Program by Diane Michelsen, J.D., M.S.W.

Finding Your Assisted Reproductive Program

Diane Michelsen, J.D., M.S.W.

(From INCIID Insights Newsletter - Published April 2005)

 

Achieving a Successful Outcome Through Intrauterine Insemination and Ovulation Induction by Scott M. Slayden,MD, Joe B. Massey, MD

The United States Census Bureau has released our country's latest census results indicating a total U.S. population of nearly 300 million. This statistic suggests that exceptional fertility is an inherent trait of the human species - this is far from the truth.

INCIID the Media

Carla Van Devander's son Jackson was conceived through in vitro fertilization, the cost of which was financed thanks to donated medical treatment through a scholarship from  INCIID.

Tags: 

Help Now Online

Help Now Online: the story of INCIID's birth.

NOVARELTM HCG ADDED TO FERRING INFERTILITY LINE

Ferring Pharmaceuticals broadens its line of infertility products with the addition of Novarelä (Chorionic Gonadotropin for Injection, USP).

Outcome Based Reporting Expected to Garner Support for Insurance Coverage for IVF

Outcome based reporting of statistics which are accurate, reliable and audited could help to garner support for infertility insurance coverage for such procedures as IVF

LETTER TO THE EDITOR of O Magazine

INCIID (the International Council on Infertility Information Dissemination) applauds O Magazine and Barbara Seaman’s efforts (“The Terrifying Truth about Fertility Drugs”, February 2004) to inform the public about potential concerns in infertility treatment. 

FERRING PHARMACEUTICALS PRESENTS DATA ON NEW INFERTILITY TREATMENTS AT THE PACIFIC COAST REPRODUCTIVE SOCIETY MEETING

Results of clinical trials evaluating Ferring Pharmaceuticals' infertility treatments -- a human-derived follicle stimulating hormone (hFSH) and a purified human menopausal gonadotropin (hMG), which are currently under investigation -- were presented at the 50th Annual Pacific Coast Reproductive Society Meeting in Rancho Las Palmas, CA, April 17 to 21, 2002. 

Pages

Single donation

Make Donation

  • Other: $

Donate now
Subscribe to RSS - press